SB-Serta 50 mg (Tablet)
Unit Price: ৳ 6.00 (50's pack: ৳ 300.00)
Medicine Details
| Category | Details |
|---|---|
| Generic | Sertraline hydrochloride |
| Company | Sunman birdem pharma ltd |
Title
- SB-Serta
Categories
- Antidepressant
- Psychiatric Medication
- Sertraline-based Medication
- Prescription Medication
Description
- Indicated for the treatment of major depressive disorder (MDD)
- Indicated for the treatment of obsessive-compulsive disorder (OCD)
- Indicated for the treatment of panic disorder (PD)
- Indicated for the treatment of post-traumatic stress disorder (PTSD)
- Indicated for the treatment of social anxiety disorder (SAD)
- Indicated for the treatment of premenstrual dysphoric disorder (PMDD)
- Selective inhibitor of CNS neuronal reuptake of 5-HT
- Increases 5-HT concentrations at synaptic clefts
- Facilitates sustained activity at postsynaptic receptor sites
- Improves depression
- Reduces serotonin turnover in the brain
- Once daily administration
- Starting Dose for Major depressive disorder: 50 mg
- Therapeutic Range for Major depressive disorder: 50-200 mg
- Starting Dose for Obsessive-compulsive disorder: 50 mg
- Therapeutic Range for Obsessive-compulsive disorder: 50-200 mg
- Starting Dose for Panic disorder, Post-traumatic stress disorder, Social anxiety disorder: 25 mg
- Therapeutic Range for Panic disorder, Post-traumatic stress disorder, Social anxiety disorder: 50-200 mg
- Starting Dose for Pediatric Patients (ages 6-12 years old) with Obsessive-compulsive disorder: 25 mg
- Therapeutic Range for Pediatric Patients with Obsessive-compulsive disorder: 50-200 mg
- Adjustable dosage for PMDD patients
- Continuous administration option for PMDD
- Intermittent administration option for PMDD
- Dosage increase for non-responding patients
- Interactions with drugs tightly bound to plasma proteins
- Interactions with Cimetidine
- Interactions with CNS active drugs like Diazepam
- Interactions with Hypoglycemic drugs
- Interactions with Atenolol
- Contraindicated in patients with known hypersensitivity to Sertraline
- Contraindicated in patients with moderate to severe hepatic impairment
- Possible side effects: upset stomach, diarrhoea, constipation, vomiting, dry mouth, loss of appetite, weight changes, drowsiness, dizziness, headache, pain, burning or tingling in the hands or feet, excitement, sore throat
- Safety during pregnancy not established
- Excretion in breast milk
- Effects on nursing infant not yet established
- Consideration of discontinuation of breastfeeding during treatment
- Precaution in case of liver problems
- Precaution in case of kidney diseases
- Precaution in case of seizures
- Precaution in case of heart problems
- Precaution in case of allergies
- Potential dizziness or drowsiness
- Caution in activities requiring alertness
- Caution in elderly use
- Avoid after taking monoamine oxidase inhibitor in the last five weeks
- Risk of suicidal thinking and behavioral changes
- Close monitoring after 2 to 3 weeks of use
- Belongs to therapeutic class of SSRIs & related anti-depressant drugs
- Storage temperature not to exceed 30°C
- Keep out of the reach of children